J.Safra Asset Management Corp Procept Bio Robotics Corp Transaction History
J.Safra Asset Management Corp
- $1.31 Billion
- Q2 2025
A detailed history of J.Safra Asset Management Corp transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, J.Safra Asset Management Corp holds 8 shares of PRCT stock, worth $432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 9
11.11%
Holding current value
$432
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
304Shares Held
42.1MCall Options Held
286KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$277 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$189 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$116 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$76.6 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$64.2 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.41B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...